Correlation between Anti-CCP Titer and Body Mass Index Score in Rheumatoid Arthritis Patients in Cipto Mangunkusumo Hospital by Isbagio, Harry & Fitriah, Khadijah
  
Correlation between Anti-CCP Titer and Body 
Mass Index Score in Rheumatoid Arthritis 
Patients in Cipto Mangunkusumo Hospital 
 
 
 
 
 
1 General Medicine, 
Faculty of Medicine, 
University of Indonesia, 
Jakarta, Indonesia 
2 Division of 
Rheumatology, 
Department of Internal 
Medicine, University of 
Indonesia, Jakarta, 
Indonesia 
 
Corresponding author: 
Khadijah Fitriah, 
khadijahfitriah@gmail. 
com, 
 
Khadijah Fitriah1, Harry Isbagio2 
 
 
Abstract  
Background Rheumatoid Arthritis (RA) is a chronic 
systemic inflammation that attacks and damages 
joints of upper and lower extremities. RA causes 
morbidity and disability, hence, affects the quality of 
life. Chronic inflammation, as the disease progressing 
causes lowering of body mass index in RA patients. 
Titer of anti-CCP is specific for RA which indicates 
the progressivity and severity of the disease. Study 
about anti-CCP titer and body mass index has not 
been done in Indonesia. Therefore, this study done to 
understand the correlation between anti-CCP titer 
and body mass index score in rheumatoid arthritis 
patients in Cipto Mangunkusumo hospital.  
Method The design of this study is cross-sectional 
study with 42 samples. The data included anti-CCP 
titer, body weight, height, and body mass index are 
collected from patients’ medical records.  
Result RA patients in Cipto Mangunkusumo 
hospital in 2012-2016 with negative and positive 
anti-CCP titer consecutively are 28.6% and 71.4%. 
The result of this correlation study is p>0.05; r-0.03.  
Conclusion In conclusion, there is no 
correlation between anti-CCP titer and body 
mass index score in RA patients in Cipto 
Mangunkusumo hospital Keywords: Anti-
CCP; Body Mass Index; Rheumatoid Arthritis  
 
 
Introduction 
Rheumatoid Arthritis (RA) is a chronic systemic 
inflammation that attacks and damages joints of upper 
and lower extremities.1,2 RA causes morbidity and 
disability, hence, affects the quality of life and also 
raise mortality risk.1 Various studies have been carried 
out over the last 100 years to discover the etiology and 
characteristics of RA.1 Although the exact etiology of 
RA is still unclear, yet strong evidence suggests that 
autoimmunity is one of the causes.3 Other study states 
that genetic factor is one of the predisposing factor of 
RA.1,3  
There are more than 20 million people in the 
world who suffer from RA. Rheumatoid arthritis is 
the most common inflammatory arthritis of 0.5-1% 
of the world’s population.2 The prevalence of RA 
in Indonesia is <0.4%, with incidence rate in 
women and men is 2.5: 1.4. This disease can occur 
at different ages, with the most common age is 
 
 
 
 
 
between 40 to 70 years, and the incidence increases 
with age.2  
Serological test to diagnose RA is usually seen 
from rheumatoid factor (RF).2 RF is detected in 70-
80% of RA patients and used as RA diagnosis 
markers.2 However, these antibodies are not 
specific to RA. It can be detected in other diseases 
and in 3-5% of normal person .2 In recent years the 
study of antibody cyclic citrullinated peptide (CCP) 
shown it has highly specific and predictive to RA 
because it can be detected several years before 
clinical manifestations appears and associated with 
joint destruction.2,5 Anti-CCP can be used to 
evaluate the disease’s progressivity, it means when 
anti-CCP was high, progression of the disease was 
high too.1-2,5  
Systemic inflammation in patients with active 
chronic disease such as RA correlates significantly 
with weight loss (thereby significantly affecting body 
mass index), which is called rheumatoid cachexia in 
RA patients.6 A study found that radiographic images 
of joint damage were fewer in patients with higher 
body mass index. It was also mentioned that the 
mortality rate in RA patients decreased with 
increasing of body mass index.6  
Genetic factors play a role in the occurrence of 
RA disease, and the progressivity of RA may be 
affected by the body mass index score.3,4 Similarly, 
anti-CCP could describe the disease’s activity. 
Studies about correlation between anti-CCP and 
body mass index in RA patient have not been done 
in Indonesia. 
 
Method 
This is cross-sectional study. Subjects of this study are 
RA patients in Cipto Mangunkusumo hospital (both in 
Center of Cipto Mangunkusumo hospital and Kencana 
cluster Cipto Mangunkusumo hospital), all of subjects 
were evaluated by analyzing their medical records 
who have fulfilled the inclusion criteria, such as 
patients who have been diagnosed with RA> 12 
months based on ACR / EULAR 2010 criteria, is ≥18 
years old, with medical record contained anti-CCP 
titer and body mass index (BMI) score (with 
maximum BB examination in 3 months after/before 
anti-CCP titer test). The exclusion criteria of this study 
are patients with other diseases that may cause 
changes 
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in body mass index score, such as diabetes mellitus, cancer, 
and other chronic diseases.  
The calculation of the samples number was performed by 
a single proportion hypothesis test. The sampling method used 
was the consecutive sampling. Furthermore, the normality of 
the data is checked by using Saphiro Wilk test. If the results 
of the data are normally distributed, correlation bivariate 
analysis will be performed by Pearson test. If the data are not 
normally distributed, the correlation bivariate analysis will be 
performed by Spearman test7,8 
 
Result 
Data obtained in this study is 42. Characteristic of subjects is 
presented in Table 1. Result of correlation test is presented in 
Table 2 and Table 3. 
 
Tabel 1. Samples Demographic Data  
 
Variable Frequency (n) Percentage (%) 
   
Gender   
Woman 39 92.8 
Man 3 7.2 
Age group   
>18-19 years 0 0 
20-29 years 4 9.5 
30-39 years 7 16.7 
40-49 years 7 16.7 
50-59 years 17 40.5 
≥60 years 7 16.7 
Anti-CCP Titer   
Negative 12 28.6 
Positive 30 71.4 
Body Mass Index Score   
Underweight 2 4.8 
Normal 14 33.3 
Overweight 18 42.9 
Obese 8 19 
   
 
Tabel 2. Median Score of Anti-CCP Titer  
dan Body Mass Index Score  
 
Variable Result 
  
Anti-CCP Titer 32.2 (1.08–800)* 
Body Mass Index Score 23.5 (15.9–30.7)*   
*:not normally distributed data, data presented in median (range) 
 
 
Tabel 3. Result of Correlation Spearman’s Test  
 
Anti-CCP Titer (N=42)   
 r p 
Body Mass Index Score -0.03 0.851 
   
 
The anti-CCP titer and body mass index score were abnormal 
based on the normality test results. Therefore, the correlation test 
used Spearman test. In this study, the result of p value was 0.851 
(p> 0.05). Thus, statistically there was no correlation between 
anti-CCP titer and body mass index score. 
 
 
The r value obtained was -0.03, so it can be interpreted that the 
anti-CCP titer is inversely correlated with the body mass index 
score with very poor correlation. 
 
Discussion 
In this study, the number of female is more than men. This is 
consistent with the epidemiologic datawhich stated prevalence of 
RA in women is higher than in men.9 The result was consistent 
with study conducted by Sotoudehmanesh et al which has the 
percentage of female 84.4%.10 The other study conducted by 
Symmons et al, obtained the ratio of RA in men and women 
consecutively 1.5:3.6. 11  
Sex hormones play a role in immune response.12 Estrogen 
plays a role in humoral immunity, while androgens and 
progesterone act as immune suppressors. Higher estrogen 
levels in women may cause RA is more occur in women than 
in men.12,13  
In this study, the median age of the sample is 49.5 years. This 
value corresponds to incidence of RA which increases in fourth 
to sixth decade of life.2 This value is also in accordance with 
research conducted by Symmons et al, which found the 
prevalence of RA is high in individuals aged> 40 years.  
11 This value is different from the research done by Cutolo 
which found the most common RApatients are > 70 years old, 
although RA could be appeared at different ages. 12 
 
In this study, the data obtained 71.4% from total samples with 
a positive anti-CCP titer. This is consistent with a study by Pruijn 
et al5 that received a seropositive anti-CCP result of 70% of a total 
of 17,359 samples tested for anti-CCP. The distributions of 
weight are obese group (19%), overweight (42.9%), normal 
(33.3%), and underweight (4.8%). This result is different from the 
research conducted by Baker et al14, which obtained sample with 
normal and underweight group (42.1% total), with overweight 
sample (33.5%) and obese 
 
(24.3%). 
 
Correlation between Anti-CCP Titer and Body Mass 
Index Score There was no correlation between anti-CCP 
titer and body mass index score (p>0.05). Moreover, r value 
is -0.03, it can be interpreted that the anti-CCP titer sample is 
inversely correlated with the body mass index score with a 
very weak association. Then, the probability result caused by 
chance (coincidence) r = -0.03 is 85%. 
The results of this study are in accordance with research 
conducted by Baker et al15 which explained that there was no 
interaction between CCP seropositivity with statistical 
changes in body mass index score. It was also mentioned that 
there were several confounding factors that may affect one or 
both variables in the sample of the study, such as drug use, 
smoking habits, and initial weight before illness.15  
Study conducted by Curtis et al16, found that there was body 
weight increasing in RA patients who took prednisone (doses of 
14─16 mg/day).16 It was also mentioned that the disease activity 
in the sample group was low.16,17 This statement was different 
from study conducted by Baker et al15, which found that there was 
no association between prednisone use and weight gain in RA 
patients. However, it caused prednisone 
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dose which used in the sample group was low (7 mg/day). 
Therefore, different results may be obtained if the prednisone 
dose is increased.15  
In a study conducted by Baker et al15 found that MTX therapy 
reduced the risk of BMI degradation when it compared with non-
MTX as controls.15 Based on study conducted by Brown et al18, 
patients who took anti-TNF therapy had BMI repair. However, 
this result different from study by Baker et al15 which found no 
association between anti-TNF and weight gain. In addition, 
therapy using infliximab for six months also causes reduce anti-
CCP titers.19  
Research samples used in the Baker et al15 study were 
patients who had undergone pharmacological therapy such as 
MTX and/or anti-TNF. This may explain the absence of 
correlation between anti-CCP titer and body mass index score, 
which is due to an improvement in body mass index score 
along with RA treatment.  
Smoking is a risk factor of RA.20 Chronic inflammation in 
lung mucosa caused by cigarette, it play role in RA initiation 
as an environmental trigger.21-23 In a study conducted by Baker 
et al15 there was found that smoking habits were associated 
with weight loss.13 Study conducted by Clair et al24 and 
Audrain-McGovern et al25 found that there was a significant 
increase in body weight in patients who did not smoke and 
patients who quit smoking. Nicotine in cigarettes may play a 
role in suppressing hunger.25  
Based on a research conducted by Baker et al15, weight 
gain is still occured in RA patients until they reach age 50, and 
it will decrease over age.15 Weight loss is more common in the 
elderly, it may be caused by systemic cytokines and hormones 
which play a role in satiety.26  
High BMI score in early disease associated with greater 
weight loss.15In this study result, the majority of samples are 
overweight and obese, there is no weight loss. However, it can 
not be proven because the researchers did not take the patient’s 
initial weight data before the onset of the disease began.  
Higher or lower body mass index is caused by many 
factors, such as physical activity, socio-economic status, 
nutrition, educational level, alcohol consumption, 
contraceptive use of oral contraceptives in women, 
psychosocial factors, and television viewing habits.27-28  
Physical activity is associated with lower BMI.29 In RA 
patients, physical activity may improve condition of 
cardiorespiratory system, muscle mass, decrease fat mass, and 
increase body strength and body function without 
exacerbating disease activity or worsening joint damage.30 
Therefore, American College Sports Medicine recommends 
physical activity for at least 30 minutes per day several times 
a week.31 In general, RA patients have low physical activity. 
This condition caused by joint stiffness, pain, metabolic 
changes which causes muscle weakness and decrease muscle 
mass. 31-33  
The socio-economic status is positively associated with 
body mass index. The socio-economic status is related to 
lifestyle such as physical activity and nutrition.27 A study 
conducted by Handayani34 in Tangerang, Indonesia, in elderly, 
higher amounts of energy/calories were consumed in 
individuals with higher incomes. The study found that 
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socio-economic status was positively correlated with body 
mass index score.34 Economic status is also related to physical 
activity. Individuals in low economic status are associated 
with higher physical activity.27 
 
Study Limitation 
In this study, sample’s weight loss was measured by total body 
weight or BMI score. However, according to Masuko35, BMI 
score is poor to describe the muscle/protein loss that occurs in 
rheumatoid cachexia. Body Lean Mass (total mass reduced by 
fat mass) should be used in this research. Body lean mass can 
be measured by using waist circumference data or other 
gauges.  
From the discussion, there are many factors that can affect the 
weight score and also anti-CCP titer. In this study, the 
researchers aren’t consider whether the patient is taking drugs 
or not and period of treatment. Retrieval time of anti-CCP in 
this study is heterogeneous, while pharmacological 
procedures can affect both weight and anti-CCP titer. 
 
Conclusion 
Based on the results, it can be concluded that nutritional status of 
patients with rheumatoid arthritis in Cipto Mangunkusumo 
hospital from 2012 to 2016 is obese (19%), overweight (42.9%), 
normal (33.3%), and underweight (4.8%). The percentage of 
rheumatoid arthritis patients in Cipto Mangunkusumo hospital 
from 2012 to 2016 with negative and positive titer were 28.6% 
and 71.4% consecutively. There is no correlation between anti-
CCP titer and body mass index score in rheumatoid arthritis 
patients in Cipto Mangunkusumo hospital in 2012-2016. We 
recommend using body lean mass to measure weight changes and 
to analyze the confounding factors, such as drug use, smoking 
activity, nutrition, and socio-economic factors as future research 
variables. 
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